BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5606372)

  • 1. [Initial clinical results on the use of combined isoniazid plus trypsin and chymotrypsin in pulmonary tbc].
    Concina E; Spataro C
    G Mal Infett Parassit; 1967 Jul; 19(7):447-9. PubMed ID: 5606372
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood and urine INH levels, administered orally alone or combined with proteolytic enzymes].
    Concina E; Penna R; Grattarola M; Spataro C
    G Mal Infett Parassit; 1967 Jul; 19(7):450-1. PubMed ID: 5609921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biweekly treatment of pulmonary tuberculosis by isoniazid and streptomycin with or without initial continuous phase. Results obtained in Algeria].
    Larbaoui D; Abderrahim K
    Rev Tuberc Pneumol (Paris); 1968 Nov; 32(7):939-48. PubMed ID: 5729100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation with oral administration of a combination of trypsin, chymotrypsin and tetracycline in odontostomatology].
    De Fabianis E; Vercellino V
    Minerva Stomatol; 1968 Aug; 17(8):692-6. PubMed ID: 5246862
    [No Abstract]   [Full Text] [Related]  

  • 5. [Association of ethionamide, isoniazid and ethambutol in the therapy of pulmonary tuberculosis].
    Zanotelli F
    Fracastoro; 1967; 60(6):594-607. PubMed ID: 5617704
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic study of anti-inflammatory enzymatic synergism].
    Prudhon
    Inf Dent; 1967 Mar; 49(12):1205-7. PubMed ID: 5228156
    [No Abstract]   [Full Text] [Related]  

  • 7. [Capreomycin, ethambutol and isoniazid in the original treatment of pulmonary tuberculosis].
    Rey JC; Pilheu J; Iannello J; González Montaner LJ
    Prensa Med Argent; 1967 Sep; 54(27):1375-6. PubMed ID: 5619888
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative results of medium and increased doses of isoniazid in the triple treatment of overt pulmonary tuberculosis].
    Favez G; Maillard JM; Vouilloz M
    Schweiz Med Wochenschr; 1968 Sep; 98(36):1392-5. PubMed ID: 5693896
    [No Abstract]   [Full Text] [Related]  

  • 9. [Difficulties in the treatment of pulmonary tuberculosis in a patient rapidly inactivating isoniazid (INH)].
    Bednarski Z
    Wiad Lek; 1984 Jun; 37(12):937-40. PubMed ID: 6523868
    [No Abstract]   [Full Text] [Related]  

  • 10. [The new combined antituberculous drug: the original combined antituberculous drug dioxazid].
    Glushkov RG; Sokolova GB; Krylova LIu; Stebaeva LF; Sharova SA
    Probl Tuberk Bolezn Legk; 2007; (3):20-5. PubMed ID: 17500222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of the effect of a combination of tetracycline-L-methylenbysine with trypsin and alpha-chymotrypsin on acute and chronic oral infections].
    Ip Cheong A; Campillo A; Catalini JC
    Rev Circ Argent Odontol; 1968 Jul; 31(2):45-7. PubMed ID: 5246376
    [No Abstract]   [Full Text] [Related]  

  • 12. [Utilization in the treatment of tuberculosis in children of a single daily oral dose of isoniazid and para-aminosalicylic acid].
    Sarrouy C; Viallier J; Vaillaud JC
    Ann Pediatr (Paris); 1967 Mar; 14(3):219-24. PubMed ID: 5614546
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biweekly treatment of pulmonary tuberculosis with isoniazid and streptomycin, with or without initial continuous phase. Results obtained in Algiers].
    Larbaoui D; Abderrahim K
    Rev Tuberc Pneumol (Paris); 1968 Jun; 32(4):572-3. PubMed ID: 5758995
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of phlegmous and abscesses of dental origin with tetracycline-L-Metilenlisina plus trypsin-alphachymotripsin by mouth].
    Cacchione E; Tallarico A
    Rev Circ Argent Odontol; 1970 Apr; 33(1):42-8. PubMed ID: 5272739
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of an antibiotic-enzyme combination in odontostomatological practice].
    Pignanelli M
    Minerva Stomatol; 1968 Aug; 17(8):686-91. PubMed ID: 5246861
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [One-year results of initial therapy of cavernous pulmonary tuberculosis with isoniazid, streptomycin and ethionamide].
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Gruzlica; 1965 Jul; 33(7):565-70. PubMed ID: 5849562
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of pulmonary tuberculosis by the one-time administration of preparations depending on the degree of isonicotinic acid hydrazide inactivation].
    Oliferovskaia RP
    Sov Med; 1972 Apr; 35(4):104-7. PubMed ID: 4662426
    [No Abstract]   [Full Text] [Related]  

  • 20. [The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis].
    Priakhina VN; Kolpakov MA; Kolpakov AR; Zyrianova TV; Mokhina OG
    Probl Tuberk Bolezn Legk; 2005; (6):55-8. PubMed ID: 16078725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.